Literature DB >> 15261714

Analysis of SYNJ1, a candidate gene for 21q22 linked bipolar disorder: a replication study.

Pavla Stopkova1, Jan Vevera, Ivo Paclt, Ilja Zukov, Herbert M Lachman.   

Abstract

Linkage analysis has shown that chromosome 21q22 may contain a candidate gene for bipolar disorder (BPD). One potential 21q22 candidate gene we previously analyzed is SYNJ1, which encodes synaptojanin 1, an inositol 5-phosphatase. Previous mutation screening of SYNJ1 identified three rare functional variants, one of which is a polymorphic variant near the intron 12-oxon 12 border. The rare variants were found only in a total of four BPD patients and no controls, and a trend toward significance was found for the intron 12 polymorphism. In an analysis of a new set of 84 bipolar patients, none of the rare variants were detected. There was an increase in allele 2 for the intron 12 polymorphism, similar to our original study, but the result was not significant. The combined data from both studies continue to show a trend toward significance for allele 2 homozygotes in BPD. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261714     DOI: 10.1016/j.psychres.2004.03.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

Review 1.  The structure of phosphoinositide phosphatases: Insights into substrate specificity and catalysis.

Authors:  FoSheng Hsu; Yuxin Mao
Journal:  Biochim Biophys Acta       Date:  2014-09-28

2.  Sparse reduced-rank regression detects genetic associations with voxel-wise longitudinal phenotypes in Alzheimer's disease.

Authors:  Maria Vounou; Eva Janousova; Robin Wolz; Jason L Stein; Paul M Thompson; Daniel Rueckert; Giovanni Montana
Journal:  Neuroimage       Date:  2011-12-22       Impact factor: 6.556

3.  The Sac domain-containing phosphoinositide phosphatases: structure, function, and disease.

Authors:  FoSheng Hsu; Yuxin Mao
Journal:  Front Biol (Beijing)       Date:  2013-08

Review 4.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02

5.  Longevity candidate genes and their association with personality traits in the elderly.

Authors:  Michelle Luciano; Lorna M Lopez; Marleen H M de Moor; Sarah E Harris; Gail Davies; Teresa Nutile; Robert F Krueger; Tõnu Esko; David Schlessinger; Tanaka Toshiko; Jaime L Derringer; Anu Realo; Narelle K Hansell; Michele L Pergadia; Anu-Katriina Pesonen; Serena Sanna; Antonio Terracciano; Pamela A F Madden; Brenda Penninx; Philip Spinhoven; Catherina A Hartman; Ben A Oostra; A Cecile J W Janssens; Johan G Eriksson; John M Starr; Alessandra Cannas; Luigi Ferrucci; Andres Metspalu; Margeret J Wright; Andrew C Heath; Cornelia M van Duijn; Laura J Bierut; Katri Raikkonen; Nicholas G Martin; Marina Ciullo; Dan Rujescu; Dorret I Boomsma; Ian J Deary
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-12-27       Impact factor: 3.568

6.  Synaptic polarity depends on phosphatidylinositol signaling regulated by myo-inositol monophosphatase in Caenorhabditis elegans.

Authors:  Tsubasa Kimata; Yoshinori Tanizawa; Yoko Can; Shingo Ikeda; Atsushi Kuhara; Ikue Mori
Journal:  Genetics       Date:  2012-03-23       Impact factor: 4.562

7.  Disease gene characterization through large-scale co-expression analysis.

Authors:  Allen Day; Jun Dong; Vincent A Funari; Bret Harry; Samuel P Strom; Dan H Cohn; Stanley F Nelson
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

Review 8.  Phosphoinositide phosphatases in a network of signalling reactions.

Authors:  Daniel Blero; Bernard Payrastre; Stéphane Schurmans; Christophe Erneux
Journal:  Pflugers Arch       Date:  2007-06-29       Impact factor: 4.458

Review 9.  Synaptojanin 1 mutation in Parkinson's disease brings further insight into the neuropathological mechanisms.

Authors:  Valérie Drouet; Suzanne Lesage
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.